Winner Profile
Yishan Liu
CEO, Shanghai Kaibao Pharmaceutical
Industry: Pharmaceuticals
Company size: Small
Published: 2016-10-17
Is Shanghai Kaibao Pharmaceutical a good stock investment?
Based on the annual Obermatt CEO of the Year analysis, Yishan Liu (Shanghai Kaibao Pharmaceutical) earned the following Obermatt pins for the management performance.
Obermatt accolades Yishan Liu
| Year | Pin | Category |
|---|---|---|
| 2016 |  |
Investment Performance |
| 2015 |  |
Operating Performance |
| 2014 |  |
Operating Performance |
|
Combined Performance | |
|
Growth Performance | |
|
Investment Performance |
Yishan Liu was included in the competition among China Top 100 Growth Companies (China) (current winners). See the winners of the other competitions or how the CEOs performed over all competitions.
Performance Overview Yishan Liu
In summary, Yishan Liu obtained the following achievements in the individual Obermatt categories by participating in the Obermatt rankings (averages of all evaluated rankings are shown for this CEO, also for other companies):
CEO performance is displayed relative to that of other CEOs that competed in the same categories for the same number of competitions. A ranking of 59 in Combined Performance indicates that Yishan Liu was better than 59% of all other CEOs that were analyzed as part of the China Top 100 Growth Companies – China for three participations in Obermatt CEO competitions. Yishan Liu’s average ranking can be found in the Multi-Year Rankings for China Top 100 Growth Companies - China.